Last updated: 22 January 2021 at 4:30pm EST

Acquisition Corp Eli Lilly ... Net Worth




The estimated Net Worth of Acquisition Corp Eli Lilly ... is at least $2.25 Tausend dollars as of 22 January 2021. Acquisition Lilly owns over 34,284,789 units of Prevail Therapeutics Inc stock worth over $2,246 and over the last 4 years Acquisition sold PRVL stock worth over $0.

Acquisition Lilly PRVL stock SEC Form 4 insiders trading

Acquisition has made over 1 trades of the Prevail Therapeutics Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently Acquisition bought 34,284,789 units of PRVL stock worth $771,407,753 on 22 January 2021.

The largest trade Acquisition's ever made was buying 34,284,789 units of Prevail Therapeutics Inc stock on 22 January 2021 worth over $771,407,753. On average, Acquisition trades about 34,284,789 units every 0 days since 2021. As of 22 January 2021 Acquisition still owns at least 100 units of Prevail Therapeutics Inc stock.

You can see the complete history of Acquisition Lilly stock trades at the bottom of the page.



What's Acquisition Lilly's mailing address?

Acquisition's mailing address filed with the SEC is LILLY CORPORATE CENTERLILLY CORPORATE CENTER, , INDIANAPOLISINDIANAPOLIS, ININ, 4628546285.

Insiders trading at Prevail Therapeutics Inc

Over the last 5 years, insiders at Prevail Therapeutics Inc have traded over $0 worth of Prevail Therapeutics Inc stock and bought 36,931,845 units worth $816,407,705 . The most active insiders traders include Acquisition Corp Eli Lilly ..., Peter A. Thompson und Advisors Llc Orbi Med Capit.... On average, Prevail Therapeutics Inc executives and independent directors trade stock every 96 days with the average trade being worth of $138,767,762. The most recent stock trade was executed by Acquisition Corp Eli Lilly ... on 22 January 2021, trading 34,284,789 units of PRVL stock currently worth $771,407,753.



What does Prevail Therapeutics Inc do?



Complete history of Acquisition Lilly stock trades at Prevail Therapeutics Inc

Insider
Trans.
Transaktion
Gesamtpreis
Acquisition Corp Eli Lilly ...
Kauf $771,407,753
22 Jan 2021


Prevail Therapeutics Inc executives and stock owners

Prevail Therapeutics Inc executives and other stock owners filed with the SEC include: